Cancer Management:A Multidisciplinary ApproachMedical, Surgical & Radiation OncologyContributors to Cancer Management:

Article

Contributors to Cancer Management:A Multidisciplinary ApproachMedical, Surgical & Radiation Oncology

Contributors

Thomas E. Ahlering, MD
Dennis S. Chi, MD
Steven R. Alberts, MD
Warren Chow, MD
Penny R. Anderson, MD
Lawrence R. Coia, MD
Kathleen W. Beekman, MD
Jay S. Cooper, MD
Al B. Benson III, MD
Jorge E. Cortes, MD
J. Sybil Biermann, MD
Jeffrey Crawford, MD
Charles D. Blanke, MD
Carey A. Cullinane, MD
Eduardo Bruera, MD
Lisa M. DeAngelis, MD
Mark Buyyounouski, MD
Lawrence Driver, MD
Emiliano Calvo, MD, PhD
Joshua D. I. Ellenhorn, MD

Carmen P. Escalante, MD
Steven M. Grunberg, MD
Andrew M. Evens, DO
Bruce G. Haffty, MD
Gilbert G. Fareau, MD
John Hoffman, MD
Paul Fisher, MD
Brent K. Hollenbeck, MD
Stephen J. Forman, MD
Eric M. Horwitz, MD
Michael J. Gazda, MS
William J. Hoskins, MD
Bonnie S. Glisson, MD
Mark Hurwitz, MD
Leo I. Gordon, MD
Maha Hussain, MD
Frederic W. Grannis, Jr., MD
Jimmy J. Hwang, MD
Kathryn M. Greven, MD
James Ito, Jr., MD

Rajesh V. Iyer, MD
Jeffrey P. Lamont, MD
Sundar Jagannath, MD
Rachelle M. Lanciano, MD
Ishmael Jaiyesimi, DO
Miriam N. Lango, MD
Lori Jardines, MD
Joseph Lattanzi, MD
Aminah Jatoi, MD
Alan List, MD
Eric H. Jensen, MD
Jay S. Loeffler, MD
Hagop Kantarjian, MD
Patrick J. Loehrer, MD
John J. Kavanagh, MD
Charles Loprinzi, MD
Kemp H. Kernstine, MD, PhD
Robert Lustig, MD
Fadlo R. Khuri, MD
Robert Maki, MD, PhD
Lily Lai, MD
Adam N. Mamelak, MD
Nicole Lamanna, MD
Gary N. Mann, MD

Ellen Manzullo, MD
Bert O’Neil, MD
Kim A. Margolin, MD
I. Benjamin Paz, MD
Maurie Markman, MD
Richard Pazdur, MD
David Scott Miller, MD
Carlos A. Perez, MD
Ronald T. Mitsuyasu, MD
Louis L. Pisters, MD
Judd W. Moul, MD
Peter W. T. Pisters, MD
Benjamin Movsas, MD
Stephen P. Povoski, MD
Nikhil C. Munshi, MD
Bruce G. Redman, DO
Robert J. Myerson, MD, PhD
Paul Richardson, MD
Nicos Nicolaou, MD
John Andrew Ridge, MD, PhD
Margaret R. O’Donnell, MD
John M. Robertson, MD

Steven T. Rosen, MD
David Straus, MD
Melanie Royce, MD, PhD
Chris H. Takimoto, MD, PhD
Stephen C. Rubin, MD
Alan Valentine, MD
Paul Sabbatini, MD
Rena Vassilopoulou-Sellin, MD
Roderich E. Schwarz, MD, PhD
Lawrence D. Wagman, MD
Walter Scott, MD
Sharon M. Weinstein, MD
Marisa Siebel, MD
Lawrence M. Weiss, MD
Richard T. Silver, MD
Mark A. Weiss, MD
Douglas Skarecky, BS
Mitchell Weiss, MD
Vernon K. Sondak, MD
Jeffrey Weitzel, MD
William G. Wierda, MD, PhD
Alan W. Yasko, MD
Jane N. Winter, MD
Sriram Yennurajalingam, MD
Joachim Yahalom, MD
Sally Yowell Barbour, PHARMD
Philippe E. Spiess, MD


 

Cara H. Glynn
Sr. Editorial Director
Angela Cibuls
Project Manager
Susan Reckling
Managing Editor
Stacey Cuozzo
Production Editor
Terri Gelfand
Sr. Editorial Coordinator
Lisa Katz
Creative Director
Jeannine Coronna
Publishing Operations Director
Beth Scholz
Publisher
Melissa Warner
Group Vice President/General Manager

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
A phase 0 trial is seeking to assess the feasibility of aiding anti-cancer cells with cytokines to restore their function.
Although pembrolizumab addressed a long-standing need in adjuvant kidney cancer treatment, combinations with the agent may further bolster efficacy.
“The trial will be successful, or [we’ll] declare it a success if we see at least 3 of 24 responses overall,” stated Ravi, MD, BChir, MRCP, on the phase 2 LASER trial in RCC.
Success with the 177Lu-PSMA-617 radioligand therapy would be transformative for the clear cell renal cell carcinoma treatment landscape.
5 experts are featured in this series
4 experts in this video
2 experts are featured in this series.
4 experts in this video
4 experts in this video
Related Content